Onglyza 2.5 mg

Onglyza 2.5 mg is a medicine authorised by Swissmedic under authorisation number 59390. The authorisation holder is AstraZeneca AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 February 2010 and the authorisation is valid without a time limit. ATC code A10BH03 places the medicine in the group Drugs used in diabetes.

  • Dispensing category B
  • Authorisation number 59390
  • ATC A10BH03
  • Synthetic medicines
Authorisation data
Authorisation number59390
NameOnglyza 2.5 mg
Full nameOnglyza 2.5 mg, Filmtabletten
Authorisation holderAstraZeneca AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeA10BH03
First authorisation05 February 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Onglyza 2.5 mg, FilmtablettenB05 February 2010
2Onglyza 5 mg, FilmtablettenB05 February 2010

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
128Tablette(n)A10BH0307.06.2.B
298Tablette(n)A10BH0307.06.2.B
328Tablette(n)A10BH0307.06.2.B
498Tablette(n)A10BH0307.06.2.B

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Onglyza 2.5 mg authorised in Switzerland?

Yes. Onglyza 2.5 mg is authorised by Swissmedic under authorisation number 59390, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Onglyza 2.5 mg have?

Onglyza 2.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Onglyza 2.5 mg?

The authorisation holder is AstraZeneca AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com